All the 7 Tγδ LGLL patients with STAT3 mutations were characterized by CD56− LGLs (P < 0.01, Supplementary Table 5) and symptomatic disease (100%, P < 0.05), mainly neutropenia (Supplementary Table 6). Here, STAT3 is linked to T-cell large granular lymphocyte leukemia.